Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
I-AM Capital Acquisition Company Announces Pricing of $50,000,000 Initial Public Offering
-
Maxim Group Starts IEC Electronic (IEC) at Buy
-
xG Technology (XGTI) Announces $3.2M Registered Direct Offering, Concurrent Private Placement
-
xG Technology Announces $3,200,000 Registered Direct Offering and Concurrent Private Placement
-
Intec Pharma (NTEC) Prices 10.6M Share Offering at $4.70/Sh
-
Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares
-
Omeros (OMER) Prices 3M Common Stock Offering at $22.75/Share
-
Omeros Announces Pricing of Public Offering of Common Stock
-
UPDATE: Maxim Group Starts Interpace Diagnostics Group Inc (IDXG) at Buy
-
Maxim Group Downgrades Del Mar Pharma (DMPI) to Hold
-
Zoe's Kitchen, Inc. (ZOES): Cutting PT Ahead of Tepid Results - Maxim
-
ARC Group Engages Maxim Group For Strategic Advisory Services
-
UPDATE: Maxim Group Upgrades NetApp (NTAP) to Buy
-
Maxim Group Downgrades Pure Storage (PSTG) to Hold
-
Soligenix (SNGX) PT Raised to $5 at Maxim Group; Adds Second Pivotal Trial for SGX942
-
Potbelly Corporation to Attend Maxim Group’s Chicago Summer Conference on August 16, 2017
-
Pre-Open Movers 08/11: (DRYS) (TTD) (ANW) Higher; (JCP) (SNAP) (NVDA) Lower (more...)
-
Cytori Therapeutics (CYTX): Cutting PT To $5 from $10 - Maxim
-
BioLife Solutions (BLFS): Raising PT to $6 - Maxim
-
UPDATE: Maxim Group Starts MannKind (MNKD) at Buy; Afrezza Offers Significant Upside
-
UPDATE: Maxim Group Starts Can-Fite BioPharma (CANF) at Buy; Multiple Shots On Goal with A3AR Drugs
-
Quantum to Participate in Maxim Group Chicago Summer Conference
-
Athersys (ATHX) PT Raised to $12 at Maxim Group
-
Achillion Pharmaceuticals (ACHN) PT Raised to $7 at Maxim Group
-
Vuzix Corp. (VUZI) Announces $8.63M Common Stock Offering
-
Vuzix Announces $8,625,000 Common Stock Offering
-
Cytosorbents (CTSO): Rolling Valuation To 2018 - Maxim
-
Maxim Group Downgrades GW Pharma (GWPH) to Hold
-
UPDATE: Maxim Group Downgrades Zynerba Pharmaceuticals (ZYNE) to Hold
-
Actinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock
-
Omeros Corp. (OMER) PT Raised to $24 at Maxim Group Into Results
-
Sucampo Pharmaceuticals (SCMP) PT Raised to $23 at Maxim Group on 2Q Report; 'Solid Revenues... Transformation Underway'
-
BioLife Solutions (BLFS) PT Raised to $5 at Maxim Group on Supply Agreement with Celyad for NKR-T Platform
-
Galmed Pharmaceuticals (GLMD) PT Raised to $14 at Maxim Group
-
Ecommerce Analyst Tom Forte Joins D.A. Davidson Research, Strengthening Consumer Tech Coverage
-
Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock
-
IntelliPharmaCeutics International (IPCI) PT Lowered to $2 at Maxim Group, Still Has 'Hope'
-
Arlington Asset Investment (AI) PT Lowered to $14 at Maxim Group; Reiterates Buy
-
Seagate Technology (STX) PT Lowered to $38 at Maxim Group
-
Chipotle Mexican Grill (CMG) PT Lowered to $435 at Maxim Group
-
Nasdaq Approves Listing of Biometric Software and Hardware Solutions Provider, BIO-key International, Starting Tuesday, July 25, 2017
-
Maxim Group Downgrades Potbelly Corp (PBPB) to Hold
-
Q2 PIPE Market Slows Slightly, Hovering at the $20B Mark, as Heights Capital, Latham & Watkins, Kirkland & Ellis Lead Way
-
Inovio Pharma (INO) Prices 12.5M Shares at $6
-
Inovio Announces Pricing of Public Offering of Common Stock
-
Vertex (VRTX) PT Raised to $195 at Maxim Group
-
UPDATE: AEterna Zentaris (AEZs) PT Raised to $4 at Maxim Group; Macrilen Could Become the New Standard
-
NASDAQ Listed MYnd Analytics Inc. Announces Closing of $8.79 Million Public Offering
-
Pre-Open Stock Movers 07/19: (AEZS) (VRTX) (SNI) Higher; (DRYS) (NTRS) (HDP) Lower (more...)
-
StreetInsider Premium Hot Research Recap 7/19

